Chat about Beximco Pharma accounts information. See how Beximco Pharma is performing financially.

Beximco Pharma Accounts Summary


Date of Accounts 20152014201320122011
StandardIFRSIFRSIFRSIFRSIFRS
      
 MillionsMillionsMillionsMillionsMillions
Income Statement31-12-201531-12-201431-12-201331-12-201231-12-2011
Revenue12,965.5111,206.8910,490.709,289.127,890.24
Operating Profit / Loss2,851.282,418.182,324.272,207.881,988.48
Net Interest-708.97-724.31-636.59-645.41-567.65
Pre Tax Profit2,337.132,109.562,093.591,909.831,677.85
Post Tax Profit1,954.281,528.301,404.761,319.391,198.53
Profit for the Period1,954.281,528.301,404.761,319.391,198.53
Equity Holders of Parent Company1,954.281,528.301,404.761,319.391,198.53
Minority Interestsn/an/an/an/an/a
      
Continuing EPS     
Earnings per Share (Basic)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
Earnings per Share (Diluted)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
Earnings per Share (Adjusted)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
Continuing and Discontinued EPS     
Earnings per Share (Basic)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
Earnings per Share (Diluted)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
Earnings per Share (Adjusted)5.06 BDT4.15 BDT3.82 BDT4.33 BDT3.93 BDT
      
Dividend per Share0.01 BDTn/a BDTn/a BDTn/a BDTn/a BDT
      
 MillionsMillionsMillionsMillionsMillions
Balance Sheet31-12-201531-12-201431-12-201331-12-201231-12-2011
Non-Current Assets     
Intangible Assets269.86235.21198.22187.08135.93
Property, Plant and Equipment22,168.1820,393.2818,364.3116,201.8615,745.49
Investments5.415.764.793.453.45
Investment Propertiesn/an/an/an/an/a
Other Financial Assets0.010.000.000.000.00
Other Non-Current Assetsn/an/an/an/an/a
Total Non-Current Assets22,443.4620,634.2518,567.3316,392.3915,884.88
      
Current Assets     
Inventories2,817.002,493.662,411.882,830.162,617.73
Trade and Other Receivables3,331.032,621.172,436.071,162.40978.22
Cash at Bank and in Hand147.00222.24595.73552.98518.77
Current Asset Investments1,539.002,475.033,026.382,686.602,193.42
Other Current Assets557.00554.18433.35965.28840.32
Total Current Assets8,391.038,366.288,903.428,197.427,148.46
      
Other Assetsn/an/an/an/an/a
Total Assets30,836.0029,000.5327,470.7524,589.8123,033.34
      
Current Liabilities     
Borrowings3,888.153,816.963,531.172,191.162,005.96
Other Current Liabilities973.85890.79851.41873.78642.20
Total Current Liabilities4,862.004,707.754,382.583,064.942,648.16
      
Net Current Assetsn/an/an/an/an/a
      
Non-Current Liabilities     
Borrowings916.93901.711,151.401,469.621,890.07
Provisions1,713.881,729.361,550.591,147.46963.38
Other Non-Current Liabilities864.11741.52610.63499.62403.60
Total Non-Current Liabilities3,494.923,372.593,312.623,116.703,257.05
      
Net Assets22,478.6320,920.1919,775.5518,408.1617,128.13
      
Capital and Reserves     
Share Capital3,862.003,678.523,503.353,046.392,517.68
Share Premium Account5,269.005,269.475,269.475,269.475,269.47
Other Reserves3,244.003,286.123,335.513,391.123,451.19
Retained Earnings10,103.008,686.087,667.226,701.185,889.78
Shareholders Funds22,478.6320,920.1919,775.5518,408.1617,128.13
      
Minority Interests / Other Equityn/an/an/an/an/a
Total Equity22,478.6320,920.1919,775.5518,408.1617,128.13
      
 31-12-201531-12-201431-12-201331-12-201231-12-2011
Operating Margin21.99%21.58%22.16%23.77%25.20%
Return on Capital Employed10.60%10.44%10.58%11.10%10.28%
Dividend Cover5.06n/an/an/an/a
Dividend Yield3.10n/an/an/an/a
PE Ratio6.305.204.304.907.90
PEG0.300.60n/a0.50n/a
Dividend per Share Growthn/a%n/a%n/a%n/a%n/a%
Net Asset Value per Share222.00 BDT206.77 BDT195.70 BDT182.14 BDT169.86 BDT